Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2025-12-24 @ 7:09 PM
NCT ID:
NCT00554203
Eligibility Criteria:
Inclusion Criteria:
* History of coronary artery disease
Exclusion Criteria:
* G6PD deficiency defined by red blood cell G6PD activity assay
* Sulfa allergy
* Aspirin allergy
* Allergy to furosemide (lasix), hydrochlorthiazide, sulfonylureas, acetazolamide (Diamox) or other carbonic anhydrase inhibitors
* SGOT, SGPT, alkaline phosphatase, total bilirubin greater than 2 times the upper limit of normal
* WBC less than 4.0 or greater than 11.0 K/UL
* Platelet count less than 150 K or greater than 450K
* Hematocrit less than 30% 7
* Serum creatinine greater than 1.5 mg/dl
* Unstable angina or acute MI within 2 weeks
* Warfarin treatment
* Immunosuppressive treatment (methotrexate, cyclosporine, etc.)
* Digoxin treatment
* Phenytoin (Dilantin) treatment
* Methenamine (Mandelamine, Urex) treatment
* Probenecid or sulfinpyrazone (Anturane, Aprazone) treatment
* Porphyria
* Symptomatic GI obstruction
* GU obstruction (not including clinical evidence of benign prostatic hypertrophy)
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00554203
Study Brief:
Protocol Section:
NCT00554203